Table 5. The odds of death affected by immune cells in patients with COVID-19.
Immune cells | Model 1 | Model 2 | ||
---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
CD3+ | 0.90 (0.74–1.00) | 0.07 | 0.90 (0.74–1.10) | 0.14 |
CD4+ | 0.74 (0.61–0.90) | 0.029 | 0.74 (0.61–0.90) | 0.029 |
CD8+ | 1.00 (0.82–1.22) | 0.63 | 0.90 (0.74–1.10) | 0.45 |
CD16+ | 0.50 (0.27–0.90) | 0.042 | 0.55 (0.30–0.99) | 0.047 |
CD20+ | 1.00 (0.67–1.49) | 0.81 | 1.00 (067–1.49) | 0.86 |
CD16+CD56+ | 0.5 (0.12–2) | 0.32 | 0.90 (0.15–2.44) | 0.14 |
*unadjusted.
**adjusted for age, sex and comorbidity.